Literature DB >> 15139995

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.

I M Stefansson1, H B Salvesen, H Immervoll, L A Akslen.   

Abstract

AIMS: The relative impact of different prognostic factors is important for endometrial carcinoma patients. The aim of our study was to examine the combined value of histological grade [International Federation of Gynaecology and Obstetrics (FIGO)] and vascular invasion in comparison with tumour cell proliferation assessed by mitotic count and Ki67. The recently proposed binary architectural grade was also evaluated, in addition to age, depth of myometrial infiltration and FIGO stage in our population-based series of 237 endometrioid carcinomas. METHODS AND
RESULTS: The tumours were studied for several histological features, including FIGO grade, binary grade, vascular invasion, mitotic count, myometrial invasion and expression of Ki67. FIGO grade was significantly associated with all investigated histological features, including Ki67 expression. Vascular invasion was significantly more frequent in FIGO grade 3 tumours, and was associated with a diffusely infiltrative growth pattern, solid growth, necrosis and deep myometrial invasion. All variables showed a highly significant relationship with patient survival in univariate analysis. In multivariate models, FIGO grade, vascular invasion, and proliferation assessed by Ki67 expression all had independent prognostic influence in this population-based study. Comparing tumour cell proliferation (Ki67) with vascular invasion as a marker of metastatic spread, the latter had a stronger survival impact.
CONCLUSIONS: Vascular invasion and tumour cell proliferation measured by Ki67 both had independent prognostic influence, and should be considered to identify aggressive tumours of the endometrioid subtype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139995     DOI: 10.1111/j.1365-2559.2004.01882.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.

Authors:  Monica Mannelqvist; Ingunn M Stefansson; Geir Bredholt; Trond Hellem Bø; Anne M Oyan; Inge Jonassen; Karl-Henning Kalland; Helga B Salvesen; Lars A Akslen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study.

Authors:  Kimberly K Leslie; Michael W Sill; Edgar Fischer; Kathleen M Darcy; Robert S Mannel; Krishnansu S Tewari; Parviz Hanjani; Jason A Wilken; Andre T Baron; Andrew K Godwin; Russell J Schilder; Meenakshi Singh; Nita J Maihle
Journal:  Gynecol Oncol       Date:  2013-02-21       Impact factor: 5.482

3.  Immunohistochemical Study of Ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study.

Authors:  R Ghalib Farhood; I Abd Ali Al-Humairi
Journal:  Arch Razi Inst       Date:  2022-02-28

4.  How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

Authors:  Angeles Rovirosa; Carlos Ascaso; Jaume Ordi; Meritxell Arenas; Izaskun Valduvieco; José-Antonio Lejarcegui; Jaume Pahisa; Aureli Torne; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

5.  Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.

Authors:  Tianbo Liu; Hongyu Gao; Meng Yang; Tingting Zhao; Yunduo Liu; Ge Lou
Journal:  Tumour Biol       Date:  2014-03-04

6.  Lipocalin 2 expression is associated with aggressive features of endometrial cancer.

Authors:  Monica Mannelqvist; Ingunn M Stefansson; Elisabeth Wik; Kanthida Kusonmano; Maria B Raeder; Anne M Øyan; Karl-Henning Kalland; Marsha A Moses; Helga B Salvesen; Lars A Akslen
Journal:  BMC Cancer       Date:  2012-05-06       Impact factor: 4.430

7.  Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer.

Authors:  Jane E Girling; Jacqueline F Donoghue; Fiona L Lederman; Leonie M Cann; Marc G Achen; Steven A Stacker; Peter Aw Rogers
Journal:  Reprod Biol Endocrinol       Date:  2010-07-08       Impact factor: 5.211

8.  Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.

Authors:  I B Engelsen; M Mannelqvist; I M Stefansson; S L Carter; R Beroukhim; A M Øyan; A P Otte; K H Kalland; L A Akslen; H B Salvesen
Journal:  Br J Cancer       Date:  2008-05-13       Impact factor: 7.640

9.  Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.

Authors:  Ingunn M Stefansson; Maria Raeder; Elisabeth Wik; Monica Mannelqvist; Kanthida Kusonmano; Gøril Knutsvik; Ingfrid Haldorsen; Jone Trovik; Anne M Øyan; Karl-H Kalland; Anne Cathrine Staff; Helga B Salvesen; Lars A Akslen
Journal:  Oncotarget       Date:  2015-04-30

10.  The anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cells.

Authors:  Wenhua Xu; Xiaoying Kong; Changqing Jiang; Xiaoyan Liu; Luo Xu
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.